LAM Group’s AstraZeneca AZN Stock Holding History

LAM Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$161	Hold	1	–	–	﹤0.01%	133
2026 Q2	$190	Hold	1	–	–	﹤0.01%	135
2026 Q1	$197	Buy	+1	New	+$193	﹤0.01%	131
2025 Q1	–	Sell	-1	Closed	-$131	–	79
2024 Q4	$131	Hold	1	–	–	﹤0.01%	128
2024 Q3	$156	Hold	1	–	–	﹤0.01%	127
2024 Q2	$156	Hold	1	–	–	﹤0.01%	126
2024 Q1	$136	Hold	1	–	–	﹤0.01%	124
2023 Q4	$135	Hold	1	–	–	﹤0.01%	120
2023 Q3	$135	Hold	1	–	–	﹤0.01%	111
2023 Q2	$143	Hold	1	–	–	﹤0.01%	110
2023 Q1	$139	Hold	1	–	–	﹤0.01%	113
2022 Q4	$136	Buy	+1	New	+$125	﹤0.01%	115

Other funds holding AZN

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

LAM Group's AZN Position: Q3 2026 in Review

LAM Group held its AstraZeneca (AZN) position steady in Q3 2026 at 1 share worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #133.

LAM Group first reported a position in AZN in Q4 2022 and has held it in 12 quarters since. The position peaked at $197 in Q1 2026. 551 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

LAM Group held 1 share of AstraZeneca worth $161 as of Q3 2026.
LAM Group left its AstraZeneca share count unchanged in Q3 2026.
AstraZeneca made up ﹤0.01% of LAM Group's portfolio in Q3 2026, its #133 holding.
LAM Group first reported a position in AstraZeneca in Q4 2022 and has held it in 12 quarters since.
LAM Group's AstraZeneca position peaked at $197 in Q1 2026.
551 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on LAM Group's 13F filing for Q3 2026, filed 26 Oct 2026.